These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 2384651

  • 1. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A, Aviram M, Gorodischer R.
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [Abstract] [Full Text] [Related]

  • 2. Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma.
    Aviram M, Tal A, Ben-Zvi Z, Gorodischer R.
    Pediatrics; 1987 Dec; 80(6):894-7. PubMed ID: 3684402
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E, Baba M.
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [Abstract] [Full Text] [Related]

  • 4. Clinical relevance of theophylline chronokinetics for asthmatic children.
    Smolensky MH, Scott PH, McGovern JP.
    Prog Clin Biol Res; 1987 Mar; 227B():259-70. PubMed ID: 3628336
    [Abstract] [Full Text] [Related]

  • 5. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J, Hill M, Stecenko A, McKenzie M, Hendeles L.
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z, Vondra V, Elis J.
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [Abstract] [Full Text] [Related]

  • 8. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL, Sette L, Vallone G, Plebani M, Messori A.
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [Abstract] [Full Text] [Related]

  • 9. [Compliance of children with bronchial asthma in long-term therapy with theophylline retard preparations].
    Köhler E, Sollich V, Schuster R.
    Kinderarztl Prax; 1993 Aug; 61(6):207-10. PubMed ID: 8411846
    [Abstract] [Full Text] [Related]

  • 10. Influence of morning or evening administration on absorption of theophylline.
    Su YM, Cheng TP, Yeh TW, Wen CY, Wang DI.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [Abstract] [Full Text] [Related]

  • 11. Salivary theophylline monitoring in asthmatic children.
    Orłowski L, Paczkowski D, Podleśny J.
    Pol J Pharmacol Pharm; 1987 Feb; 39(2):173-6. PubMed ID: 3432165
    [Abstract] [Full Text] [Related]

  • 12. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K, Backman A, Björkstén F, Finnilä MJ.
    Allergol Immunopathol (Madr); 1988 Feb; 16(1):5-9. PubMed ID: 3381714
    [Abstract] [Full Text] [Related]

  • 13. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
    D'Alonzo GE, Smolensky MH, Feldman S, Gianotti LA, Emerson MB, Staudinger HW, Sauter R, Steinijans VW.
    Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of salivary with serum levels of retard theophylline under steady-state conditions].
    Virchow C, Schmitz-Schumann M, Mansfeld J.
    Pneumologie; 1990 Feb; 44 Suppl 1():281-2. PubMed ID: 2367390
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C, Niggemann B, Wahn U.
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [Abstract] [Full Text] [Related]

  • 16. Relationship between plasma and stimulated-saliva concentrations of theophylline in asthmatic children.
    Krivoy N, Zinman P, Hoffer E, Teitelman U, Rubin A.
    Pharmatherapeutica; 1985 Nov; 4(5):285-7. PubMed ID: 4070321
    [Abstract] [Full Text] [Related]

  • 17. [Monitoring long-term therapy with theophylline preparations in children with asthma].
    Lindemann H, Bauer J, Schwandt HJ.
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):106-10. PubMed ID: 3920513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T, Bigley J.
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
    Vondra V, Spicák V, Trnavská Z, Reisová M, Pohunek P, Tomíska F.
    Cas Lek Cesk; 1989 May 05; 128(19):595-8. PubMed ID: 2743384
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.